The result: Reduced appetite You feel genuinely satisfied with less food, not deprived Fewer cravings The constant mental chatter about food quiets down Slower digestion Food stays in your stomach longer, keeping you full between meals Better blood sugar control Fewer energy crashes and hunger spikes throughout the day Cardiovascular benefits Research shows reduced risk of heart attacks and strokes in people taking GLP-1 medications This isnt willpower in a syringe
When you stop treatments, benefits slowly fade
GLP-1 medications such as semaglutide may be available as injections, oral tablets, and prescribed by licensed healthcare providers
But those same receptors exist elsewhere in body, including the liver and the pancreas
1 To appreciate what an unusual achievement this is, it helps to remember why non-peptide agonists of GLP-1 were considered so hard: the receptor is a class B G-protein-coupled receptor whose natural ligand is a 30-residue peptide that drapes across a large, shallow binding surface
The mechanisms linking obesity and MS progression involve chronic inflammation